Quick Answer
IONIS PHARMACEUTICALS INC reported Earnings Per Share Diluted of $2.38 (loss) per share for the year ending 2025.
- IONIS PHARMACEUTICALS INC showed an increase of +21.7% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from IONIS PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2008 to 2025), IONIS PHARMACEUTICALS INC's Earnings Per Share Diluted has declined by 1,152.6%.
- Historical annual values: Fiscal year 2025: $2.38 (loss) per share | Fiscal year 2024: $3.04 (loss) per share | Fiscal year 2023: $2.56 (loss) per share | Fiscal year 2022: $1.90 (loss) per share | Fiscal year 2021: $0.20 (loss) per share | Fiscal year 2020: $3.18 (loss) per share | Fiscal year 2019: $1.90 per share | Fiscal year 2018: $2.07 per share | Fiscal year 2017: $0.15 per share | Fiscal year 2016: $0.50 (loss) per share | Fiscal year 2015: $0.74 (loss) per share | Fiscal year 2011: $0.85 (loss) per share | Fiscal year 2010: $0.62 (loss) per share | Fiscal year 2009: $1.58 per share | Fiscal year 2008: $0.19 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: